Prostate cancer enzyme Prof. Dr. Frank Lampe

Prof. Dr. Frank Lampe: Alternative cancer therapy for Prostate cancer
Prostate cancer
In 2020, around 482,800 new cases of prostate cancer were registered.
Prostate cancer rarely occurs before the age of 50. For a 35-year-old man, the risk of developing prostate cancer in the next ten years is less than 0.1 percent.
For a 75-year-old, on the other hand, this risk is around five percent.
With a relative five-year survival rate of 86 percent, prostate cancer is doing relatively well.
The tumors are discovered at an early stage in around two thirds of patients.
With the help of our Prostate cancer enzyme, the spread and growth of malignant tumors can be slowed down in a targeted manner.
We recommend taking one capsule one a day.